Nasdaq:US$15.16 (+0.08) | HKEX:HK$23.30 (+0.08) | AIM:£2.20 (+0.1)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2006-07-04

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate